Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1996-10-07
1998-10-27
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514866, A61K 3105
Patent
active
058278982
ABSTRACT:
This invention is directed to methods for treatment of non-insulin-dependent diabetes mellitus, for reducing blood glucose levels, or hyperglycemia. The methods entail administering to a mammal in need of such treatment a therapeutically effective amount of a composition whose active ingredient consists essentially of a compound of the following structure or a pharmaceutically acceptable salt thereof: ##STR1## In the compound R and R' are independently H or a C.sub.1 -C.sub.20 alkyl or C.sub.2 -C.sub.20 alkenyl group which may be substituted or unsubstituted. Alternatively, R and R' are such that together a cycloalkyl or cycloalkenyl ring is formed. In the chain linking the two phenolic derivatives each of (C(R).dbd.C(R')) or (C(R)(R')) are the same or different. A and A' are independently C.sub.2 -C.sub.20 acylamino, C.sub.2 -C.sub.20 acyloxy, C.sub.2 -C.sub.20 alkanoyl, C.sub.2 -C.sub.20 alkoxycarbonyl, C.sub.1 -C.sub.20 alkoxyl, C.sub.1 -C.sub.20 alkyl amino, C.sub.2 -C.sub.20 alkyl carboxyl, amino, C.sub.2 -C.sub.20 carbalkoxyl, carboxyl, cyano, halo, hydroxy. B and B' are independently H, C.sub.2 -C.sub.20 alkanoyl, C.sub.3 -C.sub.20 alkenoyl, C.sub.2 -C.sub.20 alkenyl, C.sub.2 -C.sub.20 alkoxycarbonyl, C.sub.1 -C.sub.20 alkyl, aroyl, aralkanoyl, C.sub.2 -C.sub.20 carbamoyl, or phosphate. The invention is also directed to methods of treatment using a bisphenolic compound in conjunction with another hypoglycemic or hypolipidemic agent.
REFERENCES:
patent: 2373192 (1945-04-01), Lauer
patent: 2528355 (1950-10-01), Fletcher et al.
patent: 2644822 (1953-04-01), Pearl
patent: 2644823 (1953-04-01), Kauck et al.
patent: 2734088 (1956-02-01), Knowles et al.
patent: 3529066 (1970-09-01), Barnhart
patent: 3934034 (1976-01-01), Manning
patent: 4562298 (1985-12-01), Parkhurst et al.
patent: 4695590 (1987-09-01), Lippman
patent: 4708964 (1987-11-01), Allen
patent: 4774229 (1988-09-01), Jordan
patent: 4880637 (1989-11-01), Jordan
patent: 4954659 (1990-09-01), Parkhurst et al.
patent: 5008294 (1991-04-01), Jordan et al.
patent: 5409690 (1995-04-01), Howell et al.
patent: 5559105 (1996-09-01), Bryan et al.
Takahashi et al., 1990, "Elevated Plasma Endothelin in Patients with Diabetes Mellitus", Diabetologia 33:306-310.
Band et al., 1994, "Effects of inhibitors of lipoxygenase and cyclo-oxygenase enzymes on insulin secretion from Islets of Langerhans", Pharmacol. Comm. 4:285-294.
Bandoni et al., 1971, "Survey of Argentine medicinal plants. I. Folklore and phytochemical screening", Lloydia 35:69-77.
Brinker, 1993/94, "Larrea tridentata (D.C.) Coville (Chaparral or Creosote Bush)", Brit. J. Phytother. 3:10-29.
Christopher, 1976, School of Natural Healing (Christopher Publication, Provo, Utah).
Clapp, 1852, "Report on medical botany", Transactions of the American Medical Association V:750-751.
Dimayuga et al., 1986, "Traditional medicine of Baja California Sur (Mexico) I.", J. Ethnopharm. 17:183-193.
Dimayuga et al., 1987, "Traditional medicine of Baja California Sur (Mexico) II.", J. Ethnopharm. 20:209-222.
Guo et al., 1994, "Hypoglycemic and antiplatelet constituents of Taxus mairei", Chinese Pharm. J. 46:175-183.
Haworth et al., 1934, "The constituents of guaiacum resin. Part II. Synthesis of dl-guaiaretic acid dimethyl ether", J. Chem. Soc. pp. 1423-1429.
Hrdlicka, 1908, "Physiological and medical observations", Bureau of American Ethnology pp. 242, 244-245.
Ide and Buck, 1948, "The synthesis of benzoins", Org. React. 4:269-304.
Kellet et al., 1993, "Effect of nordihydroguaiaretic acid on glucose absorption, metabolism and (Na.sup.+ +K.sup.+)--ATPase activity in rat jejunum", Biochem. Pharm. 45:1932-1935.
Kimura et al., 1994, "Diabetes mellitus-induced enhancement of prostaglandin F.sub.2.alpha. -responses is inhibited by lipoxygenase-but not cyclooxygenase-inhibitors in mesenteric veins and arteries of mouse and rat", Jpn. J. Pharmacol. 64:65-70.
Lieberman et al., 1947, "A synthesis of nordihydroguaiaretic acid", J. Am. Chem. Soc. 69:1540-1541.
Metz et al., 1983, "A role for the lipoxygenase pathway of arachidonic acid metabolism in glucose-and glucagon-induced insulin secretion", Life Sciences 32:903-910.
Metz et al., 1982, "Lipoxygenation of arachidonic acid: a pivotal step in stimulus-secretion coupling in the pancreatic beta cell", Endocrinology 111:2141-2143.
North, 1908, "The native tribes of lower California", American Anthropologist 10:236-250.
Olsen, et al., 1991, A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck, J. Amer. Acad. Derm. 24:738-743.
Perez and Anesini, 1994, "Inhibition of Pseudomonas aeruginosa by Argentinean medical plants", Fitoterapia 65:169-172.
Perry et al., 1972, "Synthesis of lignans. I. Nordihydroguaiaretic acid", J. Orc. Chem. 37:4371-4376.
Robertson, 1984, "Arachidonic acid metabolism, the endocrine pancreas, and diabetes mellitus", Pharmac. Ther. 24:91-106.
Schroeter et al., 1918, "Uber die konstitution der Guajacharz-subztanzen", Ber. 51:1587.
Turk et al., 1985, "Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion", Biochem. Biophys. Acta. 834:23-26.
Vogel, 1970, American Indian Medicine (University of Oklahoma Press, Norman, Oklahoma).
Waller and Gisvold, 1945, "A phytochemical investigation of Larrea divaricata cav.", J. Amer. Pharm. Ass. Sci. 34:78-81.
Wilkinson and Orenberg, 1987, "Effects of nordihydroguaiaretic acid, phloretin, and phloridzin on the activity of adenylate cyclas, lipoxygenase and hexose transport, and growth of cultured keratinocytes", Int. J. Derm. 26:660-666.
Wilson et al., 1989, "Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation", J. Nerosurg. 71:551-557.
Winkelman, 1989, "Ethnobotanical treatments of diabetes in Baja California Norte", Medical Anthropol. 11:255-268.
Winkelman, 1986, "Frequently used medicinal plants in Baja California Norte", J. Ethnopharm. 18:109-131.
Yamamoto et al., 1983, "Modulation of insulin secretion by lipoxygenase products of arachidonic acid", J. Biol. Chem. 12149-12152.
Zamora et al., 1992, "A comparison of the cytotoxicity of nordihydroguaiaretic acid and its derivatives", J. Tenn. Acad. Sci. 67:77-80.
Khandwala Atul S.
Luo Jian
Jordan Kimberly
Shaman Pharmaceuticals, Inc.
LandOfFree
Use of bisphenolic compounds to treat type II diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bisphenolic compounds to treat type II diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bisphenolic compounds to treat type II diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1614308